Skip to content

Muscle Mass and Function in Chinese Adults

Muscle Mass and Function in Chinese Adults

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02089971
Enrollment
412
Registered
2014-03-18
Start date
2014-03-31
Completion date
2014-12-31
Last updated
2015-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Brief summary

To describe the normal range of muscle mass and function in Chinese adults.

Detailed description

The study objective is to setup a normal range of muscle mass and function in Chinese adults.

Interventions

None listed

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to 34 Years
Healthy volunteers
Yes

Inclusion criteria

1. Young adult ages between 25 and 34 years, inclusively. 2. Adult is judged to be in good health as determined from his/her medical history as his/her self-report to the enrolling center personnel and as confirmed through a clinical examination by a physician. 3. Adult with BMI between 18.5 to 26.9. 4. Male or non-pregnant non-lactating female. Non-pregnant should be confirmed by urine pregnant test. And non-lactating is defined as postpartum more than 18 months. 5. Subject has voluntarily signed and dated an informed consent form, approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) prior to any participation in the study.

Exclusion criteria

1. Subject who is heavy manual labor. 2. Subject who is professional or semi-professional athlete or game player. 3. Subject who is physical disabilities, such as loss of hand or foot or limbs or any physical disability which may affect the physical activities and affect the distribution of muscle mass by the opinion of the study physician. 4. Subject has known chronic diseases such as endocrine system diseases (including type 1 or type 2 diabetes mellitus, or hyperthyroidism or hypothyroidism), cardiovascular diseases, liver diseases, and renal diseases as self-report. 5. Subject who has active infection of TB, HIV and hepatitis as self-report. 6. Subject who currently experiencing diarrhea or anorexia within 7days prior to the enrollment. 7. Subject who has or plans for intensive physical activities 3 days prior to the scheduled BIA measurement. 8. Subject who is thyroid malfunction (as serum fT4 level and/or serum TSH level out of the reference range of the lab) 9. Subject has implanted electronic device, orthopedic metal implantations, such as pacemaker, cardiac defibrillator, or metal hip, metal knee joint, metal fracture internal fixation, etc. 10. Subject is drug addiction or alcohol addiction. 11. Subject is anemia (as blood hemoglobin level less than 120 g/L in males and 110 g/L in females). 12. Subject is malnourished by study physician's opinion 13. Subject has active cancers as self-report 14. Subject has lost or gained more than 5% of body weight in the past 3 months 15. Subject attends other clinical trials and is not approved by AN

Design outcomes

Primary

MeasureTime frameDescription
Total skeletal muscle massTest Visit 1 (~ Day 13)Dual X-ray Absorptiometry (DXA)

Secondary

MeasureTime frameDescription
Total body fatTest Visit 1 (~ Day 13)
Total body fat free massTest Visit 1 (~ Day 13)
Total skeletal muscle massTest Visit 1 (~ Day 13)Bioelectrical Impedance Absorptiometry (BIA)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026